Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity

Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment

NCT02105168 ·Status: UNKNOWN ·Phase: NA

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

NCT05868486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

NCT04431024 ·Status: RECRUITING

Evaluation of a Novel Technique for the Discovery of New, Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer.

NCT06629233 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

NCT05600933 ·Status: ENROLLING_BY_INVITATION

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

NCT00004153 ·Status: COMPLETED ·Phase: NA

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

NCT06894576 ·Status: RECRUITING

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

NCT00349830 ·Status: RECRUITING

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

NCT00898313 ·Status: RECRUITING

Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation

NCT03265496 ·Status: TERMINATED ·Phase: NA

Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules

NCT03392402 ·Status: COMPLETED

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

NCT01209299 ·Status: COMPLETED

Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

NCT00096590 ·Status: COMPLETED

Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients

NCT01424878 ·Status: COMPLETED

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

NCT00897247 ·Status: COMPLETED

Cohort Study of Pancreatic Cancer Risk

NCT04247503 ·Status: ACTIVE_NOT_RECRUITING

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT01441089 ·Status: RECRUITING

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

NCT04406831 ·Status: RECRUITING

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

NCT02470819 ·Status: WITHDRAWN ·Phase: NA

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

NCT00039676 ·Status: ACTIVE_NOT_RECRUITING

Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation

NCT02412579 ·Status: COMPLETED

Evaluation of Molecular Markers in Adrenal Tumors

NCT01348698 ·Status: TERMINATED

Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer

NCT00283530 ·Status: TERMINATED

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

NCT01109420 ·Status: RECRUITING

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

NCT01390597 ·Status: COMPLETED